We are live on
!
Find out more
TGI
TRV GP IV Portfolio holdings
AUM
$267M
1-Year Est. Return
965.83%
This Fund
S&P 500
This Quarter
Est. Return
-41.04%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
–
AUM
$109M
AUM Growth
-$51M
(-32%)
Cap. Flow
+$39.3M
Cap. Flow
% of AUM
35.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$39.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
OPL
WAM
IP
SIA
CFG
EU
PC
ALC
TRV GP IV's Q1 2020 Portfolio in Review
As of Q1 2020, TRV GP IV held 3 positions worth $109M, down 32% from $160M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP IV deployed $39.3M of net new capital in Q1 2020, opening 1 new position. Its largest new stake was Revolution Medicines: 1,419,900 shares worth $31.1M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP IV's largest Q1 2020 buy was Revolution Medicines: 1,419,900 shares worth $31.1M.
- TRV GP IV's ten largest holdings make up 100% of its $109M portfolio in Q1 2020.
- TRV GP IV opened 1 new position and closed 0 in Q1 2020.
- TRV GP IV's portfolio value fell 32% quarter-over-quarter to $109M.
Based on TRV GP IV's 13F filing for Q1 2020, filed 11 May 2020.